Abstract
Abstract: This study aimed at evaluating whether derivatization of luteinizing hormone-releasing hormone (LHRH) peptide with an amphiphilic lipoamino acid moiety could allow, along with other technological and/or pharmacokinetic advantages, to improve its encapsulation in liposomes, potentially driving its further body distribution and cellular uptake. Experimental data confirmed that a lipophilic derivative of LHRH was efficiently incorporated in various liposomal systems, differing in lipid composition and surface charge, and obtained using different methods of production. Incubation of liposomes, loaded with a fluorescent derivative of the LHRH prodrug, with NCTC keratinocytes or Caco-2 cell cultures showed that the carriers can be rapidly internalized. Conversely, the internalization of the free prodrug occurred only at very high concentrations.
| Original language | English |
|---|---|
| Pages (from-to) | 664-671 |
| Number of pages | 8 |
| Journal | Pharmaceutical Development and Technology |
| Volume | 21 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 17 Aug 2016 |
| Externally published | Yes |
Keywords
- Amphiphilicity
- cell uptake
- fluorescence microscopy
- lipoamino acids
- LUVET liposomes
- MLV liposomes
- REV liposomes
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver